Clinical Trial Update: Pharmacogenomics of Antiplatelet Response [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update from Johns Hopkins investigates how genetics influence responses to antiplatelet therapy in people with atherosclerosis, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Johns Hopkins University | Conditions: Atherosclerosis | Phase 4 | Status: COMPLETED | Results posted: 2017-01-09